Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy an (Q44839094)
Jump to navigation
Jump to search
scientific article published in February 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy an |
scientific article published in February 2004 |
Statements
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4 (English)
Ursula Schmidt-Erfurth
Neil M Bressler
Mohammad Azab
Mustapha Benchaboune
Kevin J Blinder
Evangelos S Gragoudas
Gary Edd Fish
Yong Hao
Laurie Haynes
Jennifer I Lim
Ugo Menchini
Jordi Mones
Michael J Potter
Al Reaves
Philip J Rosenfeld
Andrew Strong
Xiang Yao Su
Jason S Slakter
John A Sorenson
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group
Verteporfin in Photodynamic Therapy (VIP) Study Group
1 February 2004